サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1373932

補体標的治療薬市場：タイプ別、用途別、投与経路別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Complement-Targeted Therapeutics Market, By Type, By Application, By Route of Administration, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 300 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
補体標的治療薬市場：タイプ別、用途別、投与経路別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年10月01日
発行: AnalystView Market Insights
ページ情報: 英文 300 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

補体標的治療薬市場規模は2022年に72億80万米ドルとなり、2023年から2030年にかけてCAGR 10.5%で拡大

補体標的治療薬市場-市場力学

希少疾患や課題疾患に対する効果的な治療に対するアンメット・メディカル・ニーズが市場の需要を促進

過去において、PNHや非定型溶血性尿毒症症候群（aHUS）のような補体系に関連する様々な疾患は、理解不足と特異的治療法の不足を特徴としていました。エクリズマブやラブリズマブのような補体標的薬の登場は、これらの疾患と闘っている人々の見通しを劇的に変え、かつては実行可能な代替療法が乏しかった状況において救命療法を提供することになっています。この成果は、希少疾患だけでなく、自己免疫疾患や炎症性疾患に広く応用される補体標的薬の研究と投資の増加に拍車をかけた。この開発は、患者の転帰の改善と生活の質の向上を約束するものです。

補体標的治療薬市場-主な洞察

弊社の調査アナリストによる分析によると、補体標的治療薬の世界市場は、2023年から2030年までの予測期間を通じて、年間約10.5%の成長率を記録する見通しです。

補体標的治療薬分野は、主に希少な難病を対象とした効果的な治療に対するアンメットメディカル需要の高まりによって、大幅な成長が見込まれています。

タイプ別セグメンテーションでは、2022年は発作性夜間血色素尿症が圧倒的なシェアを占めています。

用途別では、病院薬局が2022年の主要カテゴリーとして際立っています。

地域的には、北米が2022年の主要な収益源として浮上しました。

補体標的治療薬市場-セグメンテーション分析：

補体標的治療薬の世界市場は、タイプ、用途、投与経路、地域を含むいくつかの主要な次元で構成されています。

タイプ別では、市場は3つの主要セグメントに分類される：発作性夜間血色素尿症および非定型溶血性尿毒症症候群（AHUS）です。特筆すべきは、発作性夜間血色素尿症分野が市場を独占していることです。補体標的治療薬市場は、発作性夜間ヘモグロビン尿症（PNH）への対応に特に重点を置いており、効果的な薬剤に対する切実な需要が市場を牽引しています。PNHは、溶血を特徴とする希少で生命を脅かす可能性のある血液疾患です。エクリズマブのような薬剤は、溶血を減少させ、患者のQOLを向上させることでPNH治療に革命をもたらし、この疾患の管理におけるこれらの薬剤の重要性を浮き彫りにしています。

補体標的治療薬市場-地理的洞察

地理的な観点から、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカなどの地域に広がっています。これらの地域内では、個々の国がビジネスのダイナミクスを形成する上で重要な役割を果たしています。

北米の補体標的療法市場は、多くの要因によって継続的な成長を示しています。第一に、この地域の高齢化は加齢黄斑変性症（AMD）を含む加齢関連疾患の発生率の上昇に寄与しており、補体標的治療薬は大きな可能性を秘めています。第二に、発作性夜間ヘモグロビン尿症（PNH）や非定型溶血性尿毒症症候群（aHUS）のような希少な補体関連疾患に対する認識の高まりが、専門的な治療に対する需要を高め、市場の拡大をさらに促進しています。

補体標的治療薬市場-競合情勢：

補体標的治療薬分野の競合情勢は、ダイナミズムとイノベーションによって特徴付けられます。既存企業は、主にソリリス（エクリズマブ）を主力薬として、歴史的に重要な地位を占めてきました。しかし、中小企業を含む多様な製薬企業が補体標的薬を開発し、ポートフォリオを拡大することでこの分野に参入し、競合が激化しています。この競争の激化は、新薬の領域における研究と技術革新を促進し、結果として補体関連疾患の治療選択肢を高めることになります。

目次

第1章 補体を標的とした治療薬市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 補体を標的とした治療薬の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 補体をターゲットとした治療薬産業の研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 補体を標的とした治療薬市場：COVID-19症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 補体を標的とした治療薬市場情勢

  • 補体をターゲットとした治療薬市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 補体を標的とした治療薬市場- 種類別

  • 概要
    • タイプ別セグメントシェア分析
    • 発作性夜間血色素尿症
    • 非定型溶血性尿毒症症候群（AHUS）

第8章 補体を標的とした治療薬市場- 用途別

  • 概要
    • アプリケーション別のセグメントシェア分析
    • 病院薬局
    • 小売薬局
    • オンライン薬局

第9章 補体を標的とした治療薬市場- 投与経路別

  • 概要
    • 投与経路別セグメントシェア分析
    • 静脈内投与
    • 経口または皮下の形態

第10章 補体をターゲットとした治療薬市場-地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 補体をターゲットとした治療薬業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Alexion Pharmaceuticals
    • Regeneron Pharmaceuticals
    • Apellis Pharmaceuticals
    • Ra Pharmaceuticals
    • Omeros Corporation
    • Achillion Pharmaceuticals
    • Idera Pharmaceuticals
    • Novartis
    • Janssen Pharmaceuticals
    • Biogen
    • Genentech
    • Amgen
    • CSL Behring
    • Alnylam Pharmaceuticals
    • Argenx

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Complement-targeted Therapeutics Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Complement-targeted Therapeutics Market, by Type 2018-2030 (USD Million)
  • TABLE Complement-targeted Therapeutics Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Complement-targeted Therapeutics Market, by Application 2018-2030 (USD Million)
  • TABLE Complement-targeted Therapeutics Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Complement-targeted Therapeutics Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE Complement-targeted Therapeutics Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Complement-targeted Therapeutics Market, by Region 2018-2030 (USD Million)
  • TABLE North America Complement-targeted Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Complement-targeted Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Complement-targeted Therapeutics Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Complement-targeted Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Complement-targeted Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Complement-targeted Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Complement-targeted Therapeutics Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Complement-targeted Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Complement-targeted Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Complement-targeted Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Complement-targeted Therapeutics Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Complement-targeted Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Complement-targeted Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Complement-targeted Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Complement-targeted Therapeutics Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Complement-targeted Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Complement-targeted Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Complement-targeted Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Complement-targeted Therapeutics Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Complement-targeted Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)

List of Figures

  • FIGURE Complement-targeted Therapeutics Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Type segment market share analysis, 2022 & 2030
  • FIGURE Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Route of Administration segment market share analysis, 2022 & 2030
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Complement-targeted Therapeutics Market share and leading players, 2022
  • FIGURE Europe Complement-targeted Therapeutics Market share and leading players, 2022
  • FIGURE Asia Pacific Complement-targeted Therapeutics Market share and leading players, 2022
  • FIGURE Latin America Complement-targeted Therapeutics Market share and leading players, 2022
  • FIGURE Middle East and Africa Complement-targeted Therapeutics Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Complement-targeted Therapeutics Market share analysis by country, 2022
  • FIGURE Germany Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Complement-targeted Therapeutics Market share analysis by country, 2022
  • FIGURE India Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Complement-targeted Therapeutics Market share analysis by country, 2022
  • FIGURE Brazil Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Complement-targeted Therapeutics Market share analysis by country, 2022
  • FIGURE Saudi Arabia Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1809

REPORT HIGHLIGHT

Complement-targeted Therapeutics Market size was valued at USD 7,200.8 Million in 2022, expanding at a CAGR of 10.5% from 2023 to 2030.

Complement-targeted medications represent a category of medical treatments designed to modulate the complement system, a pivotal component of the immune system. This system plays a dual role in safeguarding the body against infections while maintaining tissue equilibrium. However, dysregulation can lead to autoimmune disorders, inflammatory conditions, and tissue damage. Complement-targeted medications aim to restore immunological balance by either inhibiting or enhancing specific complement components. They hold the potential to address a diverse array of conditions, ranging from rare hereditary diseases like paroxysmal nocturnal hemoglobinuria (PNH) to more common issues such as age-related macular degeneration (AMD). These therapies mark a promising frontier in the realm of precision medicine.

Complement-targeted Therapeutics Market- Market Dynamics

Unmet medical need for effective treatments for rare and challenging diseases to propel market demand

In the past, various diseases related to the complement system, such as PNH and atypical hemolytic uremic syndrome (aHUS), were characterized by a lack of understanding and a shortage of specific treatments. The advent of complement-targeted medications like eculizumab and ravulizumab has dramatically transformed the outlook for individuals grappling with these conditions, offering life-saving therapies in situations where viable alternatives were once scarce. This accomplishment has catalyzed increased research and investment in complement-targeted drugs, not only for rare diseases but also for broader applications in autoimmune and inflammatory disorders. This development holds the promise of improved patient outcomes and a better quality of life.

Complement-targeted Therapeutics Market- Key Insights

According to the analysis provided by our research analyst, the global market for Complement-targeted Therapeutics is poised to witness an annual growth rate of approximately 10.5% throughout the forecast period spanning from 2023 to 2030.

The Complement-targeted Therapeutics sector is anticipated to experience substantial growth, primarily driven by the escalating unmet medical demands for effective treatments aimed at rare and challenging diseases.

When considering the segmentation by Type, the year 2022 witnessed Paroxysmal Nocturnal Haemoglobinuria as the dominant category.

In terms of Application segmentation, Hospital Pharmacies stood out as the leading category in 2022.

Geographically, North America emerged as the primary revenue generator in the year 2022.

Complement-targeted Therapeutics Market- Segmentation Analysis:

The Global Complement-targeted Therapeutics Market is structured around several key dimensions, including Type, Application, Route of Administration, and Region.

Within the Type category, the market is classified into three primary segments: Paroxysmal Nocturnal Haemoglobinuria and Atypical Haemolytic Uraemic Syndrome (AHUS). Notably, the Paroxysmal Nocturnal Haemoglobinuria sector assumes dominance in the market. The critical demand for effective medications is a driving force in the market for complement-targeted therapeutics, with a specific focus on addressing Paroxysmal Nocturnal Hemoglobinuria (PNH). PNH is a rare and potentially life-threatening blood disorder characterized by hemolysis. Medications like eculizumab have revolutionized PNH treatment by reducing hemolysis and enhancing the quality of life for patients, underscoring the significance of these drugs in managing the condition.

Complement-targeted Therapeutics Market- Geographical Insights

From a geographical standpoint, this market extends across regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Within these regions, individual countries play a significant role in shaping business dynamics.

The market for complement-targeted therapies in North America has demonstrated continuous growth, driven by a multitude of factors. Firstly, the region's aging population contributes to a higher incidence of age-related conditions, including age-related macular degeneration (AMD), for which complement-targeted medications hold significant promise. Secondly, the increasing awareness of rare complement-related disorders such as paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) has heightened the demand for specialized treatments, further fostering market expansion.

Complement-targeted Therapeutics Market- Competitive Landscape:

The competitive landscape in the field of complement-targeted therapies is marked by dynamism and innovation. Established entities have historically held prominent positions, primarily due to their flagship drug Soliris (eculizumab). Nevertheless, as a diverse range of pharmaceutical companies, including both small and medium-sized enterprises, enter the arena by developing complement-targeted medications and expanding their portfolios, competition intensifies. This heightened competition fosters research and innovation in the realm of new medications, consequently enhancing treatment options for complement-related disorders.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL COMPLEMENT-TARGETED THERAPEUTICS MARKET KEY PLAYERS

  • Alexion Pharmaceuticals
  • Regeneron Pharmaceuticals
  • Apellis Pharmaceuticals
  • Ra Pharmaceuticals
  • Omeros Corporation
  • Achillion Pharmaceuticals
  • Idera Pharmaceuticals
  • Novartis
  • Janssen Pharmaceuticals
  • Biogen
  • Genentech
  • Amgen
  • CSL Behring
  • Alnylam Pharmaceuticals
  • Argenx

GLOBAL COMPLEMENT-TARGETED THERAPEUTICS MARKET, BY TYPE

  • Paroxysmal Nocturnal Haemoglobinuria
  • Atypical Haemolytic Uraemic Syndrome (AHUS)

GLOBAL COMPLEMENT-TARGETED THERAPEUTICS MARKET, BY APPLICATION

  • Hospital Pharmacies
  • Retail Pharamacies
  • Online Pharmacies

GLOBAL COMPLEMENT-TARGETED THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION

  • Intravenously
  • oral or subcutaneous forms

GLOBAL COMPLEMENT-TARGETED THERAPEUTICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Complement-targeted Therapeutics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Complement-targeted Therapeutics Market Snippet by Type
    • 2.1.2. Complement-targeted Therapeutics Market Snippet by Application
    • 2.1.3. Complement-targeted Therapeutics Market Snippet by Route of Administration
    • 2.1.4. Complement-targeted Therapeutics Market Snippet by Country
    • 2.1.5. Complement-targeted Therapeutics Market Snippet by Region
  • 2.2. Competitive Insights

3. Complement-targeted Therapeutics Key Market Trends

  • 3.1. Complement-targeted Therapeutics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Complement-targeted Therapeutics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Complement-targeted Therapeutics Market Opportunities
  • 3.4. Complement-targeted Therapeutics Market Future Trends

4. Complement-targeted Therapeutics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Complement-targeted Therapeutics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Complement-targeted Therapeutics Market Landscape

  • 6.1. Complement-targeted Therapeutics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Complement-targeted Therapeutics Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Paroxysmal Nocturnal Haemoglobinuria
    • 7.1.3. Atypical Haemolytic Uraemic Syndrome (AHUS)

8. Complement-targeted Therapeutics Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Hospital Pharmacies
    • 8.1.3. Retail Pharamacies
    • 8.1.4. Online Pharmacies

9. Complement-targeted Therapeutics Market - By Route of Administration

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 9.1.2. Intravenously
    • 9.1.3. oral or subcutaneous forms

10. Complement-targeted Therapeutics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Complement-targeted Therapeutics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Complement-targeted Therapeutics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Complement-targeted Therapeutics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Complement-targeted Therapeutics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Complement-targeted Therapeutics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Complement-targeted Therapeutics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Alexion Pharmaceuticals
    • 11.2.2. Regeneron Pharmaceuticals
    • 11.2.3. Apellis Pharmaceuticals
    • 11.2.4. Ra Pharmaceuticals
    • 11.2.5. Omeros Corporation
    • 11.2.6. Achillion Pharmaceuticals
    • 11.2.7. Idera Pharmaceuticals
    • 11.2.8. Novartis
    • 11.2.9. Janssen Pharmaceuticals
    • 11.2.10. Biogen
    • 11.2.11. Genentech
    • 11.2.12. Amgen
    • 11.2.13. CSL Behring
    • 11.2.14. Alnylam Pharmaceuticals
    • 11.2.15. Argenx

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us